ArticlePDF Available

Bakuchiol: A Retinol-Like Functional Compound Revealed by Gene Expression Profiling & Clinically Proven to have Anti-Aging Effects.

Authors:
  • Sytheon, 10 Waterview Blvd. Parsippany NJ 07054, USA
  • Sunny BioDiscovery

Abstract and Figures

The study was undertaken to compare the skin care related activities of retinol and bakuchiol, a potential alternative to retinoids. Retinol is a pivotal regulator of differentiation and growth of developing as well as adult skin. Retinoic acid is the major physiologically active metabolite of retinol regulating gene expression through retinoic acid receptor - dependant and independent pathways. Comparative gene expression profiling of both substances in the EpiDerm FT full thickness skin substitute model was undertaken. Type I, III and IV collagen and aquaporin 3 synthesis in normal human dermal fibroblasts and in were analysed by ELISA and/or histochemistry in EpiDerm FT full thickness skin model were determined. Bakuchiol is a meroterpene phenol abundant in seeds and leaves of the plant Psoralea corylifolia. We present evidence that bakuchiol, having no structural resemblance to retinoids, can function as a functional analogue of retinol. Volcano plots show the great similarity of retinol and bakuchiol gene expression. Retinol-like functionality was further confirmed for the upregulation of types I, and IV collagen in DNA microarray study and also show stimulation of type III collagen in the mature fibroblast model. Bakuchiol was also formulated into a finished skin care product and was tested in clinical case study by twice-a-day facial application. The results showed that, after twelve weeks treatment, significant improvement in lines and wrinkles, pigmentation, elasticity, firmness and overall reduction in photo-damage was observed, without usual retinol therapy-associated undesirable effects. Based on these data, we propose that bakuchiol can function as an anti-aging compound through retinol-like regulation of gene expression. This article is protected by copyright. All rights reserved.
Content may be subject to copyright.
Bakuchiol: a retinol-like functional compound revealed by gene
expression profiling and clinically proven to have anti-aging effects
R. K. Chaudhuri* and K. Bojanowski
*Sytheon Ltd., Boonton, NJ 07005, USA and
Sunny Biodiscovery, Santa Paula, CA 93060, USA
Received 04 November 2013, Accepted 25 January 2014
Keywords: anti-ageing clinical, bakuchiol, DNA microarray, histology, retinol
Synopsis
OBJECTIVE: The study was undertaken to compare the skin care
related activities of retinol and bakuchiol, a potential alternative to
retinoids. Retinol is a pivotal regulator of differentiation and
growth of developing as well as adult skin. Retinoic acid is the
major physiologically active metabolite of retinol regulating gene
expression through retinoic acid receptor dependant and indepen-
dent pathways.
METHODS: Comparative gene expression profiling of both sub-
stances in the EpiDerm FT full thickness skin substitute model
was undertaken. Furthermore, type I, III and IV collagen, as well
as aquaporin 3 expression was analyzed by ELISA and/or histo-
chemistry in human dermal fibroblasts and/or Epiderm FT skin
substitutes.
RESULTS: Bakuchiol is a meroterpene phenol abundant in seeds
and leaves of the plant Psoralea corylifolia. We present evidence that
bakuchiol, having no structural resemblance to retinoids, can func-
tion as a functional analogue of retinol. Volcano plots showed
great overall similarity of retinol and bakuchiol effects on the gene
expression profile. This similarity was confirmed by the side-by-side
comparison of the modulation of individual genes, as well as on
the protein level by ELISA and histochemistry. Retinol-like func-
tionality was further confirmed for the upregulation of types I and
IV collagen in DNA microarray study and also show stimulation of
type III collagen in the mature fibroblast model. Bakuchiol was also
formulated into a finished skin care product and was tested in clini-
cal case study by twice-a-day facial application. The results showed
that, after 12 weeks treatment, significant improvement in lines
and wrinkles, pigmentation, elasticity, firmness and overall reduc-
tion in photo-damage was observed, without usual retinol therapy-
associated undesirable effects.
CONCLUSION: Based on these data, we propose that bakuchiol
can function as an anti-ageing compound through retinol-like
regulation of gene expression.
R
esum
e
OBJECTIF: L’
etude a
et
e men
ee pour comparer les activit
es li
ees
aux soins de la peau du r
etinol et du bakuchiol, une alternative
potentielle aux r
etino
ıdes. Le r
etinol est un r
egulateur essentiel de
la diff
erenciation et de la croissance de la peau en d
eveloppement
ainsi que la peau des adultes. L’acide r
etino
ıque est le principal
m
etabolite physiologiquement actif du r
etinol qui r
egule l’expres-
sion des g
enes par des voies d
ependantes et ind
ependantes du
r
ecepteur de l’acide r
etino
ıque.
M
ETHODES: Un profilage comparatif d’expression g
en
etique de ces
deux substances dans le mod
ele substitut de la peau EpiDerm FT a
et
e entrepris. La synth
ese des collag
enes de type I, III et IV et de
l’aquaporine 3 dans des fibroblastes dermiques humains normaux
ont
et
e analys
es par ELISA et/ou en histochimie dans le mod
ele de
peau EpiDermTM FT.
R
ESULTATS: Bakuchiol est un ph
enol meroterp
ene abondant dans
les graines et les feuilles de la Psoralea corylifolia. Nous pr
esentons
des preuves que bakuchiol, n’ayant aucune ressemblance structu-
relle avec les r
etino
ıdes, peut fonctionner comme un analogue fonc-
tionnel de r
etinol. Les diagrammes de type Volcano montrent la
grande similitude de l’effet du r
etinol et du bakuchiol sur l’expres-
sion des g
enes. Cette ressemblance a
et
e aussi d
emontr
ee par la
comparaison de la modulation de l’expression de g
enes particu-
laires, appartenant a de diff
erentes groupes fonctionnelles. La fonc-
tionnalit
er
etinol -like a
et
e confirm
ee par la r
egulation
a la hausse
du collag
ene de type I et IV et aquaporine 3 au niveau de proteines
par ELISA et histochimie. Le bakuchiol a
egalement
et
e formul
e
dans un produit de soin de la peau et a
et
e test
e dans une
etude
clinique avec deux applications par jour au visage. Les r
esultats
ont montr
e que, apr
es le traitement de douze semaines, une
am
elioration significative a
et
e observ
ee dans les rides et ridules, la
pigmentation, l’
elasticit
e, la fermet
eetlar
eduction globale des
dommages du photo-vieillissement, sans les effets ind
esirables habi-
tuels associ
es
alath
erapie au r
etinol.
CONCLUSION: Sur la base de ces donn
ees, nous proposons que le
bakuchiol peut fonctionner comme un compos
e anti- vieillissement
gr^
ace
alar
eglementation de l’expression des g
enes similaire au
r
etinol.
Introduction
Retinoids have been first defined as a family of naturally occurring
compounds comprised of vitamin A (retinol) and its derivatives,
such as vitamin A aldehyde (retinal) or vitamin A acid (retinoic
acid). Retinoic acid is considered to be the active form of vitamin A
and is involved in gene regulation, leading to effects ranging from
hyperplasia to differentiation and apoptosis of normal and cancer
cells [1, 2]. The conversion of retinol to retinal by the retinol dehy-
drogenases is considered to be the rate-limiting step for the biosyn-
thesis of retinoic acid [3]. In addition to retinol dehydrogenases,
P450s 1A1, 1A2, 1B1 and 3A4 have been shown to be involved
Correspondence: Ratan K. Chaudhuri, Sytheon Ltd., 315 Wootton
Street, Boonton, NJ 07005, USA. Tel.: +201 303 5594; fax: +1 973
909 9922; e-mail: ratan@sytheonltd.com
©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie 1
International Journal of Cosmetic Science, 2014, 1–10 doi: 10.1111/ics.12117
in the metabolism of retinoic acid [4]. Human dermal fibroblasts
treated with retinol metabolize it to retinoic acid, demonstrating
the bioactivity and bioavailability of retinol in the dermis [5].
Retinol is found in a variety of foods such as beef, calf, chicken
liver, eggs and fish. It is also present in vegetables such as carrots,
squash, sweet potatoes, pumpkin and cantaloupe. Subsequent
research has resulted in a much larger class of natural and syn-
thetic compounds that are termed retinoids due to their functional
although not always structural similarity to vitamin A [6].
The epidermis is one of the major targets for the retinoic acid
signalling in adult organism. Classic retinoid activities are mainly
achieved through the transcriptional regulation of specific genes
via two classes of nuclear hormone receptors, the retinoic acid
receptors (RAR) and retinoid X receptors (RXR), each with three is-
otypes (a,b,c) and multiple isoforms [79]. All-trans retinoic acid
preferentially binds RARs and its 9-cis isomer, 9-cis retinoic acid,
binds both RARs and RXRs. The predominant retinoid receptors
found in skin are RARcand RXRa[10]. Retinoic acid receptors
exert their effects in epidermis through direct binding to epidermal
genes [11, 12] or interference with signalling of other transcription
factors [13].
Retinoic acid and its derivatives have been used as therapeutic
agents for numerous skin conditions from psoriasis to acne and
were also found to be clinically effective against wrinkles [14].
Retinol (Fig. 1A) application is believed to be a more efficient
method to deliver retinoic acid to the skin cells than direct treat-
ment with retinoic acid [15]. However, retinoid therapy using
even the newer analogues is still restricted by many undesirable
side effects, such as irritation, dryness, peeling, erythema and a
sensation of burning on the skin [16, 17]. These side effects often
result in non-compliance and discontinuation of therapy. There-
fore, there is a definite need to develop improved retinoid com-
pounds. Such compounds should have similar but not identical
gene expression pattern as compared with retinol, ideally, result-
ing in retinol-like beneficial effects, without having retinol-like
undesirable side effects. Here, we build on our preliminary findings
[18] and report that bakuchiol (Fig. 1B) a meroterpene phenol
from seeds of the plant Psoralea corylifolia [19, 20] exhibits such
retinol-like functionality.
Materials and methods
Test materials
Retinol (Fig. 1A), trade named Retinol 50 C (INCI name Retinol
and Polysorb 20), was purchased from BASF (Florham Park, NJ,
U.S.A). This product is a yellow oil containing 50% vitamin A in
polysorbate 20 and stabilizer system consisting of 3.5% BHT and
1% BHA. Bakuchiol (Phenol, 4-[1E,3S)-3-ethenyl-3,7-dimethyl-1,6-
octadinenyl; Fig. 1B)l is a phenolic compound with a monoterpene
side chain [19]. Bakuchiol belongs to a rare group of terpenoids in
which the aromatic ring system is derived from phenylpropane unit.
The material used in this study is obtained from edible seeds of Psora-
lea corylifolia, which is psoralene-depleted Bakuchiol (trade named Sy-
tenol
â
A; INCI name Bakuchiol) with a purity of about 95%.
DNA microarrays
EpiDerm FT tissues were obtained from Mattek (Ashland, MA,
U.S.A.; cat. no. EFT 212) and cultured according to the manu-
facturer’s instructions. The test materials Retinol (50%) and
Bakuchiol (100%) were dissolved in DMSO at 10 mg mL
1
(Reti-
nol) and 5 mg mL
1
(Bakuchiol), and further dilutions were made
in type I sterile water. Test materials were assayed at 10 lgmL
1
(Retinol) and 5 lgmL
1
(Bakuchiol) against 0.1% DMSO as a con-
trol. The incubation time with skin tissues was 2 days. After incu-
bation, skin tissues were harvested, frozen in liquid nitrogen and
subjected to total RNA extraction with Qiagen kit (Frederick, MD,
U.S.A). The quality of extracted RNA was validated twice by elec-
trophoresis (after extraction and before microarray analysis).
Samples were hybridized and data were analysed using human
OneArray platform from Phalanx Biotech (Palo Alto, CA, U.S.A.).
The Excel file yielding information on over 30 000 probes was then
further processed in house to retain only differences with low P
values (Pvalue cut off was 0.05) and high fold-change (the cut off
value for fold-change was 2.0).
Collagen ELISA
Retinol and bakuchiol were assayed at 10 lgmL
1
on normal
human fibroblasts grown in DMEM with 5% calf serum (Hyclone,
Salt Lake City, UT, U.S.A.). For type I and IV collagen quantifica-
tion, neonatal human dermal fibroblasts (low passage; American
Type Culture Collection, Manassas, VA, U.S.A. cat. no. PCS-201-
010, lot no. 58243223) were used. For type III collagen quantifi-
cation, human epidermal fibroblasts from a 68-year-old female
donor (p. 5, Zen-bio, cat. no. KR-F) was used. Cells were exposed
to test materials for 3 days (type I collagen quantification) or
7 days (type III and IV collagen quantification). Afterward, cell-
culture conditioned media were harvested and assayed for type I,
type III or type IV collagen by sandwich ELISA using affinity-purified
antibodies, followed by streptavidin-avidin-HRP conjugate and ABTS,
according to a standard ELISA protocol [21, 22]. The colorimetric
signal proportional to collagen content was quantified with the Bio-
Rad microplate spectrophotometer 3550-UV at 405 nm with back-
ground subtraction at 660 nm and analysed with Microplate
Manager v.2 software for Macintosh (BioRad, Hercules, CA, U.S.A.).
Histochemistry
Fort type IV collagen and aquaporin three visualization retinol
and bakuchiol were dissolved at 50 mg mL
1
in DMSO. Test sam-
ples were then further diluted in type I sterile water and tested at
final concentrations 10 lgmL
1
(Retinol) and 5 lgmL
1
(Bak-
uchiol) using EpiDermFT tissues from Mattek. Tissues were equili-
brated for 24 h and incubated with test materials or water
(negative control) for 96 h, afterward they were rinsed and fixed
in 10% buffered formalin. Paraffin sections of these tissues were
stained with a biotinylated antibody against type IV collagen (cat.
B
A
HO
OH
Figure 1 (A) Retino l. (B) Bakuchiol.
2©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
no. 1340-08 Southern Bio, Birmingham, AL, U.S.A.) or AQP3
(cat. no. sc-9885, Santa Cruz Biotechnology, Santa Cruz, CA,
U.S.A.) and developed with the ABC peroxidase staining compo-
nents (Santa Cruz Biotechnology). Slides were mounted in Perm-
mount and observed on Nikon (Tokyo, Japan) Eclipse TS100
inverted microscope at 100 magnifications. Microphotographs
were taken with Canon Rebel digital camera mounted on the
Nikon TS100 microscope.
Clinical study
General
Seventeen healthy but photo-aged subjects were recruited to this
blind study (all females; age range 4065 years). All subjects read,
understood and signed an informed consent. All subjects had
abstained from the use of moisturizing products and used only sim-
ple soap, for at least 1 week prior to treatment conditions. All test
products were supplied in identical containers. Subjects were
instructed on the use of the cream twice daily morning and even-
ing applications to the entire face for 3 months. Clinical assess-
ments of the skin of the face were performed for all participants at
baseline and following 4, 8 and 12 weeks of product use. The fol-
lowing parameters were assessed at each visit by an expert grader:
Fine Lines/Wrinkles, Roughness and Dryness, Skin Tone, Skin Elas-
ticity and Firmness, Radiance, Brightening and Overall Eye Area
Appearance. Assessment for each parameter was performed at
baseline using the following five-point ordinal severity scale:
0=None; 1 =Minimal; 2 =Mild; 3 =Moderate; 4 =Severe.
Silicone analysis profilometry
At each visit, a single silicone replica was made of the target area
and a photographic record was kept of this target for subsequent
relocation. Comparative analysis of skin profilometry was con-
ducted, using surface roughness and wrinkle depth analysis. The
heights of the replicated wrinkles were measured using Miyomoto
Surftest profilometer. Ry (depth) and Ra (mean roughness) were
recorded at each time of measuring operation. The area scanned
from each sample was clearly mapped so as to determine the same
area in respective weeks 4, 8 and 12 samples.
Photo booth
At each time point, a series of high resolution digital photographs
was collected using a photo booth equipped with Canon G7 Digital
Camera 10 MP, 69zoom. Subject positioning was reproduced
upon return visit. A light booth was used so as to provide con-
trolled reproducible light conditions. The booth consists of an array
of 8 equally spaced fluorescent tubes in a semicircular configura-
tion. The software-driven system allows the position and expression
of the test subjects to be aligned to a high degree.
Method of assessment & product application
Baseline
The expert grader performed assessment of the panelist’s face and
eye area for all the parameters as described before. Photographs
were conducted using a photo booth with a three-point head
restraint with photographs taken with frontal view, 45 degrees to
the right and 45 degrees to the left at each time point (Day 0,
Weeks 4, 8 and 12). A replica ring was used to delineate the wrin-
kle site in the crow’s feet area. Silflo was applied on the site,
allowed to dry for approximately 5 min, and the replica was
removed gently from the site.
Product application
Test Materials were distributed to the subjects. Subjects were asked to
gently massage a small amount of the test material to the crow’s feet
and eye area and then smooth over the whole face. They were asked
to apply twice a day for 12 weeks. A study diary was given to the
panelists to list the time of application, the dates and any subjective
comments that they might have in regard to the test product.
Weeks 4, 8 and 12
Panellists returned to the study site after week 4, 8 and 12 of prod-
uct use. At each study visit, panellists were clinically evaluated in
the same manner as at the baseline visit.
Statistical analysis
For each of the parameters, percent improvement from baseline
was calculated to express the efficacy of the product at each time
point (4, 8 and 12 weeks). Using the t-test, the statistical signifi-
cance of the net change from baseline (pre-application) to each
subsequent time point was assessed. Statistical significance was
defined at the P=0.05 or less level (corresponding to a 95% or
greater confidence level).
Formulated product
Formulation details are given in Table V.
Results and discussion
Bakuchiol is a meroterpene phenol abundant in seeds and leaves of
the plant Psoralea corylifolia [19, 20] and has also been isolated
from other plants, such as, P. grandulosa [23, 24], P. drupaceae
[25], Ulmus davidiana [26], Otholobium pubescens [27] and Piper lon-
gum [28]. It is widely used in Indian as well as Chinese medicine to
treat a variety of diseases. Bakuchiol has been reported to possess
anti-inflammatory [24, 2931], antioxidant [3234], anti-tumor
[35, 36], anti-bacterial [37], cytotoxic [38], heptaprotective [39]
and caspase-3 depended apoptosis [40] effects. The cytotoxicity of
bakuchiol is mainly due to its DNA polymerase 1-inhibiting activity
[41]. Recently, anti-acne activity of bakuchiol has been reported
[42]. Here, we demonstrate the anti-ageing and retinol-like func-
tionalities of bakuchiol using DNA microarray, ELISA, histochemis-
try and clinical case studies.
As human skin naturally ages, it becomes thin, lax and finely
wrinkled. Of these changes, fine lines & wrinkles and uneven pig-
mentation are most easily appreciated clinically with severity corre-
lating strongly with age. We have demonstrated through a pilot
clinical study that topical 0.5% bakuchiol treatment improves clini-
cal appearance (% improvement vs. baseline) of naturally aged/
photo-aged human skin.
DNA microarrays
As retinol affects the expression of a vast array of genes, compara-
tive gene expression profiling with retinol is a suitable method to
identify retinol-like compounds [43]. Here, we applied this method
©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie 3
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
to reveal retinol-like properties of bakuchiol. These proprieties were
first evidenced on the whole genome scale by comparing the shapes
of volcano plots of retinol- and bakuchiol-treated skin substitutes
(Fig. 2A,B). Volcano plot is a scatter graph used to identify mean-
ingful changes in large datasets, such as data from DNA micro-
array analysis, by plotting significance versus. fold-change on the
y- and x-axes, respectively. Data points with low P-values (highly
significant) appear towards the top of the plot, and with Pvalue of
0.05 being set as the threshold for statistical significance, all points
situated above the value of 1.3 on the y axis are statistically signifi-
cant. The finding that the overall shapes of retinol and bakuchiol
volcano plots are similar was the first indication of the functional
analogy between the two compounds. This was further confirmed
by the analysis of retinoid-binding and metabolizing genes; the
expression was often but not always similarly modulated
(Table I). Interestingly, both RARB and RARG are up-regulated, as
expected, by retinol but not by bakuchiol, indicating a possible
advantage of the latter in terms of side effects. Also retinol had no
effects on CRBP II and CRBP IV, whereas bakuchiol showed signifi-
cantly higher up-regulation. Furthermore, retinol causes down reg-
ulation of CRABP1 gene whereas bakuchiol causes up-regulation,
and whereas bakuchiol showed a dramatic up-regulation (82-fold
vs. placebo) of LRAT retinol showed 12.3-fold (still a very signifi-
cant) increase. These results indicate that besides being a retinol
functional analogue, bakuchiol may enhance the availability of
endogenous retinol.
Retinol and bakuchiol also showed similar modulation of genes
implicated in ECM and DEJ (Tables II and III, respectively). ECM is
the material that forms the bulk of the dermis, excluding water and
cells. Proteins and complex sugars form most of the dermal ECM, and
they are arranged in an orderly network fibres and ground sub-
stances organized by physical entanglements, opposing ionic
charges, chemical covalent bonding and cross-linking into a
biomechanically active polymer. This scaffolding structure with
regional tensile strength provided by collagens, elasticity by elastins,
Table I Description, fold-change in the DNA microarray experiment and role of modulated retinoid binding and metabolizing genes (R: retinol; B: bakuchiol)
Gene Full name Function & comments
CRBP I;
CRBP II;
CRBP IV
Cellular retinol binding
protein I, II & IV
CRBP I:R =2.6; B =4.2
CRBP II: R =NS; B =4.1
CRBP IV: R =NS; B =3.1
CRBP I mediates the cellular uptake of retinol, solubilizes and detoxifies it for further transport within the
cytoplasm and presents it to the appropriate enzymes to biosynthesize retinoic acid
N6AMT2 N-6 adenine-specific
DNA methyltransferase 2
R=NS; B =2.1
Retinoic acid resistance might be overcome by the use of epigenetic modifying agents such as DNA methyl
transferase inhibitors. Down-regulation provided by bakuchiol may reduce retinoic acid-induced toxicity
TIG1 Tazarotene-inducible gene 1 R =13.2; B =12.9
Retinoid acid (RA) receptor-responsive gene. The expression of this gene is found to be down-regulated in a
variety of human cancers as well as in acne, rosacea and psoriasis. Up-regulation by bakuchiol may provide a
solution to problem skin. Anti-acne clinical study results of bakuchiol has recently been reported [40]
DHRS9 Dehydrogenase/reductase
SDR family member
9 precursor
R=5.5; B =11.6
DHRS9 is involved in converting retinol to retinal and then to retinoic acid, the rate-limiting step for the
biosynthesis of retinoic acid
RETSAT All-trans- 13,14-dihydroretinol
saturase
R=2.9; B =2.8
RETSAT expression is involved in adipocyte differentiation
LRAT Lecithin-retinol acyltransferase R =12.3; B =82.2
Retinol esterification with long-chain fatty acid by LRAT is the key step in both absorption & storage of retinol.
CYP1A1;
CYP1A2
Cytochrome P450 CYP1A1: R =4.0; B =4.9
CYP1A2: R =3.6; B =6.7
In addition to retinol dehydrogenase, P450s 1A1 and 1A2 genes are the major human P450s
RARB; RARG Retinoic acid receptor beta -1;
Retinoic acid receptor
gamma -1
RARB: R =5.6; B =NS
RARG: R =1.8; B =NS
The actions of retinoids are generally mediated by the retinoic acid receptors (RARs alpha, beta, and gamma) and
the retinoid X receptors (RXRs alpha, beta, and gamma). Both RARB and RARG are up-regulated, as expected
by retinol but not with bakuchiol
0
2
4
6
–3 –2 –1 0 1 2 3
–Log (P value)
Log2 (fold change)
Retinol
0
2
4
6
–3 –2 –1 0 1 2 3
–Log (P value)
Log2 (fold change)
Bakuchiol
A
B
Figure 2 (A) Volcan ic plot of DNA microarray data Retinol. (B) Volcanic
plot of DNA microarray data Bakuchiol.
4©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
adhesiveness by structural glycoproteins, compressibility by proteo-
glycans hyaluronans and communicability by transmembrane
receptors, such as integrins, which exchange information between
the cytoskeleton-bound cellular elements and between cells and the
dermal extracellular matrix, provides a unique homeostatic tenseg-
rity function to the skin [44, 45]. DEJ, in turn, provides cohesion
between dermis and epidermis. With age, both, ECM and DEJ
gradually deteriorate resulting in skin thinning and morphological
Table II Description, fold-change in the DNA microarray experiment and roles of modulated genes coding for ECM components [(R: retinol; B: bakuchiol]
Gene Full name Function & comments
COL1A2;
COL4A6;
COL9A2;
COL9A3;
Collagen 1A2;
Collagen 4A6;
Collagen 9A2;
Collagen 9A3
COL1A2: R =3.3; B =1.9
COL4A6: R =6.4; B =11.2
COL9A2: R =5.6; B =6.7
COL9A3: R =4.1; B =5.8
Collagens provide scaffolding structure with regional tensile strength and elasticity; Degradation leads to fine lines and
wrinkles. Comparable fold-change observed with four collagen genes with the exception of COL3A1. This may be due
to the use of neonatal tissue in the skin substitutes. ELISA study with mature fibroblasts showed stimulation of type III
collagen.
EMILIN3
EMILIN1
Elastin microfibril
interface-located protein 3;
Elastin microfifibril
interface-located protein 1
EMILIN3:R =2.2 (NS); B =9.1
EMILIN1: R =3.4; B =2.4
The EMILINs are a family of glycoproteins of the extracellular matrix; Widely distributed in several tissues associated
with elastin and localized at the interface between amorphous elastin and microfibrils
PI3 Peptidase inhibitor
3/Elastase-specific inhibitor
R=2.5; B =2.7
Bakuchiol and retinol are expected to maintain the desired level of elastin required for maintaining the connective
tissue structure due to their up-regulation of elastase-specific inhibitor gene PI3
FLRT2;
FLRT3
Fibronectin-like
domain-containing
leucine-rich transmembrane
protein 2
FLRT2: R =NS; B =13.9
FLRT3: R =2.8 (NS); B =6.1
Fibronectins maintain the shape of cells and matrix stability
HAS3 Hyaluronan synthase 3 R =10.8; B =19.2
Hyaluronans are important for the maintenance of a highly hydrated extracellular matrix in tissues and is also involved
in cell adhesion and supports cell migration. It is synthesized by hyaluronan synthases, such as HAS-3
AQP3 Aquaporin 3 R =3.5; B =4.3
Aquaporin 3 is the water/glycerol transporting channel protein expressed in the epidermis which helps maintain the
right level of skin hydration, elasticity and barrier recovery. Both retinol and bakuchiol up-regulated AQP3
Table III Description, fold-change in the DNA microarray experiment and roles of modulated DEJ genes (R: retinol; B: bakuchiol)
Gene Full name Fold-change, function & comments
COL4A6
COL17A1
Collage alpha-6 (IV)
Collagen alpha-1(XVII)
COL4A6: R =6.4; B =11.2
COL17A1: R =3.6; B =8.7
Lamina densa mostly consists of type IV collagen, perlecan and nidogen. Through a complex inter- and intramolecular
interactions type IV collagen forms supra molecular networks that influence cell adhesion, migration, and
differentiation. Type XVII collagen is the protein component of anchoring fibrils that fortifies the attachment of the
epidermis to the dermis.
PLEC1 or
HD1
Plectin I
(Hemidesmosomal
protein 1)
R=2.7; B =6.8
Plectin, a 500-KDa protein and a constituent of the intracellular component of hemidesmosomes, attaches intermediate
filaments to both hemidesmosomes and plasma membranes of basal keratocytes
ITGB4;
ITGB6;
ITGB8;
ITGA6
Integrin beta-4;
Integrin beta-6;
Integrin beta-8;
Integrin alpha-6
ITGB4: R =3.5; B =8.0; ITGB6: R =7.5; B =7.7
ITGB8: R =0; B =3.9; ITGA6: R =0; B =3.6
Integrins are transmembrane glycoproteins and a major component of hemidesmosomes. They mediate the transfer of
information between the extracellular matrix and the interior of the cell, thereby aiding in modulating the organization of
the cytoskeleton, proliferation and differentiation. Main functions: (a) attachment of the cell to the ECM and (b) signal
transduction from ECM to the cell
LAMA3;
LAMC2
Laminin subunit alpha-3
precursor; Laminin
subunit gamma-2
precursor
LAMA3: R =4.7; B =11.0;
LAMC2: R =2.7; B =7.8
Laminins are the major non-collagenous proteins in lamina densa and are integral part of the structural scaffolding in
almost every tissue; Involved in cell differentiation, migration, adhesion as well as phenotype and survival.
CDH1 E-Cadherin R =9.4; B =21.6
One of the most important and ubiquitous types of adhesive interactions required for the maintenance of solid tissues
is that mediated by E-cadherin. E-cadherin has important functions in pluripotency and maintenance of the
differentiated state of cells
©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie 5
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
flattening [46]. Retinol is a well known inhibitor of those processes,
and the finding that bakuchiol has retinol-like functionality at the
ECM and DEJ levels makes it an interesting novel candidate for
anti-ageing applications.
Validation of DNA microarray results by ELISA and histochemistry
Collagens secreted by dermal fibroblasts are major components of
the skin extracellular matrix (type I and type III collagens) and
basement membrane (type IV collagen). In aged and photodamaged
skin, the new collagen pool is decreased due to the inferior amount
and quality of dermal fibroblasts. Therefore, we chose to measure
select collagens by ELISA and histochemistry methods to validate
the data obtained by DNA microarrays. The results, summarized in
the Table IV, confirm the upregulation of types I and IV collagen
in DNA microarray study and also show stimulation of type III
collagen in this mature fibroblast model.
To determine whether the stimulation of type IV collagens in cell
culture translates into a more robust collagen expression in 3D
skin substitute tissue, EpiDermFT tissues were incubated with bak-
uchiol or retinol at 10 lgmL
1
, and histological sections were
stained with anti-type IV collagen antibodies (Fig. 3). The stain
revealed a stronger type IV collagen signal at the dermalepidermal
junction, as compared with the water control, further corroborat-
ing the DNA microarray and ELISA results. This collagen stimula-
tory effect observed in cell culture seems to be due to the selective
metabolic activation of collagen synthesis in fibroblasts, because at
10 lg/mL
1
, bakuchiol or retinol did not enhance cell proliferation
(results not shown).
Water homeostasis of the epidermis is essential for the normal
function of the skin and stratum corneum (SC) hydration. It is a
determinant of skin appearance, mechanical properties, barrier
function and metabolism. In addition, it is indispensable in main-
taining proper water balance of the body. Dehydration of SC is a
typical feature of skin ageing, especially in photo-aged skin and of
Table IV Comparative collagen stimulatory effects of bakuchiol and retinol
as determined by ELISA in human dermal fibroblasts. The stimulatory effect
is expressed as the % of water control (100%)
Test material (10 lgmL
1
) Collagen I Collagen III Collagen IV
Bakuchiol 147 150 119
Retinol 119 148 100
ABC
Figure 3 Effect of Retinol (B) and Bakuchiol (C) on type IV collagen expression compared with non-treat ed control (A) in human EpidermFT (full thickness)
tissue substitutes. Arrows indicate dermo-epidermal juncture (basement membrane), where collagen IV is localized. Note darker band in (B) and (C) as com-
pared to (A) at this level, indicating greater type IV collagen expression.
AC
B
Figure 4 Effect of Retinol (B) and Bakuchiol (C) on aquaporin-3 expression, compared with non-treated control (A) in human EpidermFT (full thickness) tissue
substitutes. Arrows indicate aquaporin-3 staining in the basal layer, where this protein is principally localized.
6©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
several diseases, for example, eczema, atopic dermatitis, psoriasis
and hereditary ichthyosis (retinol 3.5 fold and bakuchiol 4.3 fold,
Table II) [4750]. To determine whether the increase of the !!!
expression of water channel AQP3 gene observed in DNA micro-
arrays translates into orthotropic increase at the protein level.
EpiDermFT skin substitutes were incubated with retinol, bakuchiol
and compared with the negative (water) control using immunohis-
tochemistry. It was found that both retinol and bakuchiol increased
AQP3 expression (Fig. 4) as visualized by more intense brown col-
oration in retinol and bakuchiol treated tissues located, as
expected, at stratum spinosum and corneum level. Recently, Belle-
mere et al. [51] have shown the effects of all-trans retinoic acid
(ATRA) on AQP3 expression and function both in vitro and ex
vivo. ATRA treatment increased a rapid accumulation of AQP3
transcripts in cultured normal human epidermal keratinocytes.
Also in our model of EpiDermFT skin substitute, both retinol and
bakuchiol increased AQP3 expression.
Clinical study
Taken together, these results prompted us to test bakuchiol clinically.
The formulated product containing 0.5% bakuchiol (no moisturizer
or any other active ingredients or sunscreen included in this formu-
lated product; Table V) was applied twice daily to the whole face.
Sixteen subjects of seventeen enrolled completed the study. One sub-
ject discontinued due to protocol violation. Each of the parameters
was graded on a semi-quantitative scale from 0 to 4 (0, none; 1,
minimal; 2, mild; 3, moderate; and 4, severe). With regard to subjec-
tive evaluation by experts and panelists, the obtained results for the
entire subjects are summarized in Tables VI and VII, respectively.
Evaluations were performed at baseline and then at 4, 8 and
12 weeks and the results compared versus. the baseline.
Retinol is used widely in cosmetic products for reducing the
appearance of the signs of ageing and photo-damage [52]. Retinol
is a precursor of retinoic acid. Once it penetrates skin, it is sequen-
tially oxidized to retinoic acid, causing retinoic acid-like effects, but
is notably less irritating. Currently, most of these products contain
0.1% or lower of retinol. However, even at this low concentration,
some irritation can occur [53]. It seems that bakuchiol has accept-
able skin tolerability.
Analysing the data (Table VI vs. Table VII), it is evident that %
improvement score for roughness & dryness and radiance given by
expert is significantly higher versus. the panelists’ self-evaluation. It
is interesting to note that % improvement score given by the sub-
jects, on the other hand, for fine lines and wrinkles and eye area
appearance is significantly higher than the score given by the
expert. Most of the parameters were improved significantly more
after 8 weeks compared to 4 weeks of application of bakuchiol,
showing a certain degree of cumulative beneficial effect over time.
Results obtained from silicone replica analysis using profilometry
are summarized in Table VIII. Comparison of results of day 0 (base
line) vs. 4, 8 and 12 weeks treated skin provided 7%, 13% and
20% reduction in wrinkle depth (Ry), respectively. All three
results are statistically significant (P0.01). Comparison of results
of day 0 (baseline) versus. 4, 8 and 12 weeks treated skin yielded
Table V Formulation details of bakuchiol
Ingredient Trade name/supplier % w/w
Phase A
Glyceryl stearate
and PEG-100
Arlacel 165/Uniqema 1.50
Arachidyl alcohol,
Behenyl alcohol,
Arachidyl glucoside
Montanov 202/Seppic 4.00
Dimethyl isosorbide Arlasolve DMI/Uniqema 3.00
Isohexadecane Permethyl 101A/Presperse 8.00
Dimethicone Dow Corning 200, 100 cst/Dow Corning 2.00
Bakuchiol Sytenol A/Sytheon 0.50
Phase B
Water 69.75
Propylene Glycol Propylene glycol/Lyondell 2.00
Pentylene Glycol Hydrolite-5/Symrise 3.00
Xanthan Gum Vanzan NF/Vanderbilt 0.25
Phase C
Dicaprylylether Cetiol OE/Cognis 4.00
Hydroxyethylacrylate
(and) sodium
acryloyldimethyl
taurate copolymer
Sepinove EMT 10/Seppic 1.00
Phenoxyethanol
(and) Caprylyl glycol
Optiphen or Microcare PHG 1.00
Total 100.00
Table VI Subjective evaluation by expert % improvement vs. baseline
Parameters 4 Weeks 8 Weeks 12 Weeks
Roughness & dryness 65 81 90
Fine lines/wrinkles 5 16 29
Skin tone 14 29 39
Skin elasticity/firmness 13 20 39
Radiance 24 40 52
Skin brightening 13 35 46
Eye area appearance 8 24 46
Table VII Subjective evaluation by panelists % improvement vs. baseline
Parameters 4 Weeks 8 Weeks 12 Weeks
Roughness & dryness 35 40 48
Fine lines/wrinkles 19 25 23
Skin tone 12 19 29
Skin elasticity/firmness 14 23 25
Radiance 11 17 30
Skin brightening 10 14 29
Eye area appearance 22 24 35
Table VIII Silicone replica analysis using profilometry: % reduction vs.
baseline
Parameters 4 Weeks 8 Weeks 12 Weeks
Wrinkle depth 7% 13% 20%
Skin roughness 2% 10% 21%
©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie 7
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
2%, 10% and 21% reduction in skin roughness (Ra), respec-
tively. The results at 8 and 12 weeks are statistically significant
(P0.004).
The photos (Fig. 5; before and after treatment) shown here are
representative of the results that have been obtained with bakuchi-
ol treatment for 12 weeks.
Clinical grading and comparative analysis of skin profilometric
measurements were performed at baseline and after 4, 8 and
12 weeks of application. After 8 weeks of daily application, a
significant reduction in the wrinkle depth and roughness was
observed with the product vs. baseline. These changes were even
greater after 12 weeks of product application. For example, wrinkle
depth reduction (Fig. 5C) is significantly more after 8 weeks com-
pared to 4 weeks of application of bakuchiol (subject no. M572)
showing a certain degree of cumulative beneficial effect over time.
The significant improvement in fine lines and wrinkles, elasticity,
firmness and overall reduction in signs of photodamage including
even toning effects observed after 12 weeks of treatment provided
the ultimate validation of the in vitro results and were in line with
the retinoid-type functionality of bakuchiol.
Conclusion
Given the fact that retinol and bakuchiol do not have close struc-
tural similarities, yet they exhibit a similar gene expression profile,
especially on certain key anti-ageing genes and proteins,which is
remarkable. Bakuchiol has several substantial advantages over reti-
nol, including excellent photochemical and hydrolytic stability a
good safety profile and ease to formulate due to miscibility with a
wide variety of emollients and solubilizers [18]. Bakuchiol can be
used during the day due its photostability. Interestingly, bakuchiol
is an excellent stabilizer of retinol under photo-oxidative as well as
singlet oxygen environments (not discussed here). This property
may help reduce oxidative stress caused by retinol when combined
with bakuchiol and used at concentrations higher than the physio-
logical limit [54].
This open clinical pilot study needs further confirmation of bak-
uchiol bioactivity in vivo, from vehicle- or benchmark-controlled
studies. The similarity of gene expression and protein synthesis
stimulation observed in the comparison of bakuchiol with retinol
is, however, remarkable and suggests that similar bioactivity in vivo
is probable. Taken together, this study demonstrates the potential
of bakuchiol, a true retinol-like functional compound, to become a
key ingredient for dermatological and skin care products.
Acknowledgements
The authors would like to thank Sytheon Ltd for funding this
research and to Stephanie Ma for her dedicated assistance in this
project.
References
1. Linney, E. Retinoic acid receptors: tran-
scription factors modulating gene
regulation, development, and differentia-
tion. Curr. Top. Dev. Biol. 27, 309350
(1992).
2. Balmer, J.E. and Blomhoff, R. Gene expres-
sion regulation by retinoic acid. J. Lipid Res.
43, 17731808 (2002).
3. Siegenthaler, G., Saurat, J.H. and Ponec, M.
Retinol and retinal metabolism. Relationship
to the state of differentiation of cultured
human keratinocytes. Biochem. J. 268,
371378 (1990).
4. Marill, J., Cresteil, T., Lanotte, M. et al. Iden-
tification of human cytochrome P450s
involved in the formation of all-trans-reti-
noic acid principal metabolites. Mol. Phar-
macol. 58, 13411348 (2000).
5. Bailly, J., Crettaz, M., Schifflers, M.H. et al.
In vitro metabolism by human skin and
fibroblasts of retinol, retinal and retinoic
acid. Exp. Dermatol. 7,2734 (1998).
6. Barnard, J.H., Collings, J.C., Whiting, A.
et al. Synthetic retinoids: structure-activity
relationships. Chemistry 15, 1143011442
(2009).
7. Mattei, M.G., Petkovich, M., Mattei, J.F.
et al. Mapping of the human retinoic acid
receptor to the q21band of chromosome17.
Hum. Genet. 80, 186188 (1988).
0
2
4
6
8
10
12
14
16
18
20
Base 4 weeks 8 weeks 12 weeks
Subject #M572
A
B
C
Figure 5 (A) Subject no. M572; Right view; Pre application. (B) Subject no.
M572; Right view; 12-week treatment. (C) Change in wrinkle depth in lm.
8©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
8. Chambon, P. The nuclear receptor super-
family: a personal retrospect on the first two
decades. Mol. Endocrinol. 19, 14181428
(2005).
9. Gann, A.A., Gates, P.B., Stark, D. et al.
Receptor isofrom specificity in a cellular
response to retinoic acid, Proc.Biol. Sci.
263, 729734 (1996).
10. Fisher, J.G., Talwar, H.S., Xiao, J.H. et al.
Immunological identification and functional
quantitation of retinoic acid and retinoid x
receptor proteins in human skin. J. Biol.
Chem. 269, 2062920635 (1994).
11. Jho, S.H., Radoja, N., Im, M.J. et al. Negative
response elements in keratin genes mediate
transcriptional repression and the cross-talk
among nuclear receptors. J. Biol. Chem.
276, 4591445920 (2001).
12. Jho, S.H., Vouthounis, C., Lee, B. et al. The
book of opposites: the role of the nuclear
receptor co-regulators in the suppression of
epidermal genes by retinoic acid and thyroid
hormone receptors. J. Invest. Dermatol. 124,
10341043 (2005).
13. Lee, D.D., Stojadinovic, O., Krzyzanowska,
A. et al. Retinoid-responsive transcriptional
changes in epidermal keratinocytes. J. Cell.
Physiol. 220, 427439 (2009).
14. Kafi, R., Kwak, H.S.R., Schumache, W. et al.
Improvement of naturally aged skin with
vitamin A (retinol). Arch. Dermatol. 143,
606612 (2007).
15. Fisher, G.J. and Voorhees, J.J. Molecular
mechanism of retinoid actions in skin.
FASEB J. 10, 10021013 (1996).
16. David, M., Hodak, E. and Lowe, N.J. Adverse
effects of retinoids. Med. Toxicol. Adverse
Drug Exp. 3, 273288 (1988).
17. Sorg, O., Kuenzli, S. and Saurat, J.H. Side
effects and pitfalls in retinoid therapy. In:
Retinoids and Carotenoids in Dermatology, 1st
edn (Vahlquist, A. and Duvic, M. eds), pp.
225248. Informa Healthcare, New York,
London (2007).
18. Chaudhuri, R.K. The miracle of retinol. Soap
Perfum. Cosmet. 2324 (2010).
19. Mehta, G., Nayak, U.R. and Dev, S. Merot-
erpenoids-I: Psoralea corylifolia L.-1. Bakuchi-
ol, a novel monoterpene phenol. Tetrahedron
29, 11191125 (1973).
20. Prakasarao, A.S.C., Bhalla, V.K., Nayak,
U.R. et al. Meroterpenoids. II. Psoralea coryli-
folia L. 2. Absolute configuration of (+)-bak-
uchiol. Tetrahedron 29, 11271130 (1973).
21. Dobak, J., Grzybowski, J., Liu, F.T. et al.
1,25-Dihydroxyvitamin D3 increases colla-
gen production in dermal fibroblasts. J. Der-
matol. Sci. 8,1824 (1994).
22. Zhao, H., Alexeev, A., Chang, E. et al.
Lycium barbarum glycoconjugates: effect on
human skin and cultured dermal fibroblasts.
Phytomedicine 12, 131137 (2005).
23. Labbe, C., Faini, F., Coll, J. et al. Bakuchiol
derivatives from the leaves of Psoralea glan-
dulosa.Phytochemistry 42, 12991303
(1996).
24. Backhouse, C.N., Delporte, C.L., Negrete,
R.E. et al. Active constituents isolated from
Psoralea glandulosa L. with antiinflammatory
and antipyretic activities. J. Ethnopharmacol.
78,2731 (2001).
25. Lystvan, K., Belokurova, V., Sheludko, Y.
et al. Production of bakuchiol by in vitro sys-
tems of Psoralea drupacea Bge. Plant Cell Tiss.
Organ. Cult. 101,99103 (2010).
26. Choi, S.Y., Lee, S. and Choi, W.H. Isolation
and anti-inflammatory activity of Bakuchiol
from Ulmus davidiana var. japonica. J. Med.
Food 13, 10191023 (2010).
27. Krenisky, J.M., Luo, J., Reed, M.J. et al.
Isolation and antihyperglycemic activity of
bakuchiol from Otholobium pubescens
(Fabaceae), a Peruvian medicinal plant used
for the treatment of diabetes, Biol.Pharm.
Bull. 22, 11371140 (1999).
28. Ohno, O., Watabe, T., Nakamara, K. et al.
Inhibitory effects of Bakuchiol, Bavachin
and Isobavachalcone isolated from Piper lon-
gum on melanin production in B16 mouse
melanoma cells. Biosci. Biotechnol. Biochem.
74, 15041506 (2010).
29. Ferrandiz, M.L., Gil, B., Sanz, M.J. et al.
Effect of bakuchiol on leukocyte functions
and some inflammatory responses in mice. J.
Pharm. Pharmacol. 48, 975980 (1996).
30. Pae, H.O., Cho, H., Oh, G.S. et al. Bakuchiol
from Psoralea corylifolia inhibits the expres-
sion of inducible nitric oxide synthase gene
via the inactivation of nuclear transcription
factor-jB in RAW 264.7 macrophages. Int.
Immunopharmacol. 1, 18491855 (2001).
31. Matsuda, H., Kiyohara, S., Sugimoto, S.
et al. Bioactive constituents from Chinese
natural medicines. XXXIII. Inhibitors from
the seeds of Psoralea corylifolia on production
of nitric oxide in lipopolysaccharide-acti-
vated macrophages. Biol. Pharm. Bull. 32,
147149 (2009).
32. Adhikari, S., Joshi, R., Patro, B.S. et al. Anti-
oxidant activity of bakuchiol: experimental
evidences and theoretical treatments on the
possible involvement of the terpenoid chain.
Chem. Res. Toxicol. 16, 10621069 (2003).
33. Haraguchi, H., Inoue, J., Tamura, Y. et al.
Antioxidative components of Psoralea coryli-
folia (L.). Phytother. Res. 16, 539544
(2002).
34. Haraguchi, H., Inoue, J., Tamura, Y. et al.
Inhibition of mitochondrial lipid peroxida-
tion by bakuchiol, a meroterpene from
Psoralea corylifolia.Planta Med. 66, 569571
(2000).
35. Pandey, U., Bapat, K., Samuel, G. and Venk-
atesh, M. Bioevaluation studies of 125I-Bak-
uchiol in tumor bearing animals. BARC
News Lett. 285,8891 (2007).
36. Chen, Z., Jin, K., Gao, L. et al. Anti-tumor
effects of bakuchiol, an analogue of resvera-
trol, on human lung adenocarcinoma A549
cell line. Eur. J. Pharmacol. 643, 170179
(2010).
37. Katsura, H., Tsukiyama, R.I., Suzuki, A.
et al. In-Vitro antimicrobial activities of Bak-
uchiol against oral microorganisms. Antimic-
rob. Agents Chemother. 45, 30093013
(2001).
38. Fang, J., Xin-rui, Z., Qi, W. et al. Cytotoxic
effect and mechanism of bakuchiol and bak-
uchiol combined with psoralen on HK-2 cell.
Int. J. Autom. Comput. 24,5058 (2010).
39. Cho, H., Jun, J.Y., Song, E.K. et al. Bakuchi-
ol: a hepatoprotective compound of Psoralea
corylifolia on tacrine-induced cytotoxicity in
Hep G2 cells. Planta Med. 67, 750751
(2001).
40. Park, E., Zhao, Y.Z., Kim, Y.C. et al. Bakuch-
iol-induced caspase-3-dependent apoptosis
occurs through c-Jun NH
2
-terminal kinase-
mediated mitochondrial translocation of Bax
in rat liver myofibroblasts. Eur. J. Pharmacol.
559, 115123 (2007).
41. Sun, N.J., Woo, S.H., Cassady, J.M. et al.
DNA polymerase and topoisomerase II inhib-
itors from Psoralea corylifolia.J. Nat. Prod.
61, 362366 (1998) Erratum in: J. Nat.
Prod., 66, 734 (2003).
42. Chaudhuri, R.K. and Marchio, F. Bakuchiol
in the management of acne-affected skin.
Cosmet. Toilet. 126, 502510 (2011).
43. Ishida, S., Shigemoto-Mogami, Y., Kagechika,
H. et al. Clinically potential subclasses of reti-
noid synergists revealed by gene expression
profiling. Mol. Cancer Ther. 2,4958 (2003).
44. Hayden, M.R., Sowers, J.R. and Tyagi, S.C.
The central role of vascular extracellular
matrix and basement membrane remodeling
in metabolic syndrome and type 2 diabetes:
the matrix preloaded. Cardiovasc. Diabetol. 4,
9 (2005).
45. Ingber, D.E. The architecture of life. Sci. Am.
278,4857 (1998).
46. Tim
ar, F., So
os, G., Szende, G.B. et al. Inter-
digitation index - a parameter for differentiat-
ing between young and older skin specimens.
Skin Res. Technol. 6,1720 (2006).
47. Takenouchi, M., Suzuki, H. and Tagami,
H. Hydration characteristics of pathologic
stratum corneumevaluation of bound
water. J. Invest. Dermatol. 87, 574576
(1986).
©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie 9
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
48. Thune, P. Evaluation of the hydration and
the water-holding capacity in atopic skin
and so-called dry skin. Acta Derm. Venerol.
Suppl. 144, 133135 (1989).
49. Scheuplein, R.J. and Blank, I.H. Permeability
of the skin. Physiol. Rev. 51, 702747 (1975).
50. Cao, C., Wan, S., Jiang, Q. et al. All-trans reti-
noic acid attenuates ultraviolet radiation-
induced down-regulation of aquaporin-3 and
water permeability in human keratinocytes.
J. Cell. Physiol. 215, 506516 (2008).
51. Bellemere, G., Von Stetten, O. and Oddos, T.
Retinoic acid increases aquaporin 3 expres-
sion in normal human skin. J. Invest. Derma-
tol. 128, 542548 (2008).
52. Mukherjee, S., Date, A., Patravale, V. et al.
Retinoids in the treatment of skin aging: an
overview of clinical efficacy and safety. Clin.
Interv. Aging 1, 327348 (2006).
53. Oddos, T., Roure, R., Leyden, J. et al. A pla-
cebo-controlled study demonstrates the
long-lasting anti-aging benefits of a cream
containing retinol, dihydroxy methyl
chromone (DMC) and hyaluronic acid. J. Cos-
met. Dermatol. Sci. Appl. 2,5159 (2012).
54. Gimeno, A., Zaragoz
a, R., Viv
o-Ses
e, I.
et al. Retinol, at concentrations greater
than the physiological limit, induces oxida-
tive stress and apoptosis in human dermal
fibroblasts. Exp. Dermatol. 13,4554
(2004).
10 ©2014 Society of Cosmetic Scientists and the Soci
et
e Franc
ßaise de Cosm
etologie
International Journal of Cosmetic Science, 1–10
A retinol-like functional compound R. K. Chaudhuri and K. Bojanowski
... Bakuchiol has emerged as a competitor to retinol, it has a different molecular structure [4]. It offers an improved tolerance profile, but with slightly weaker effects on some elements of comparison [5][6][7]. Bakuchiol is derived from Psoralea corylifolia, and is related to the family of psoralenes or linear furanocoumarins -the molecules causing the irritant and photosensitising effects of sap from fig, Disclaimer/Publisher's Note: The statements, opinions, and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions, or products referred to in the content. 2 umbelifera such as parsley, and citrus fruits [8,9]. ...
... The comparative in vitro tests performed here indicated that both retinol and bakuchiol bound to the RAR receptor. Previous reports indicate that this binding has an antagonistic effect (Chaudhuri and Bojanowski, 2014). The lower binding observed with SME suggests that it would induce fewer side effects than either of the two current actives. ...
... Cosmetic products that influence this network will have a longer-lasting effect on the skin. Like retinol, bakuchiol is reported to target collagen and extracellular matrix synthesis enzymes [6]. However, in our ex vivo tests, we observed a reduction in collagen I and collagen III production compared to the control following application of bakuchiol. ...
Preprint
Full-text available
Vitamin A, or retinol, is one of the most effective anti-ageing molecules, but it presents issues with photo-sensitivity and irritation. Retinol-like alternatives are emerging, but have so far been less effective. Here, we present a Silibum marianum extract (SME) as a retinol-like ingredient providing both safety and efficacy. SME was compared to the reference compound, retinol, and to the main alternative, bakuchiol. In ex vivo tests, skin explants from a 58-year-old donor were treated with pure retinol (0.1%), bakuchiol (0.2%) or SME (0.8%). After 5 days, collagen and hyaluronic acid levels were analysed. A placebo-controlled study involving 57 volunteers (ages 45-73 years) was also conducted, with products applied twice-daily for 56 days. Results were measured by AEVA-HE and VISA. Levels of collagen III were significantly increased by SME, by 23% and 16% compared to bakuchiol and retinol, respectively. Compared to bakuchiol, SME treatment increased hyaluronic acid production by 36%. In clinical tests, SME had a significantly stronger anti-wrinkle effect than bakuchiol – reducing the number of wrinkles on the forehead by 21%, and their circumference by 17% – producing effects similar to retinol, and better than bakuchiol. In the self-assessment, 43% of volunteers reported discomfort while using retinol, as compared to 0% for the SME formulation. By enhancing levels of collagen III – the youth collagen – and hyaluronic acid in the skin, SME paves the way for the maturation of collagen I fibrils and skin plumping. With its stronger efficacy compared to bakuchiol and enhanced safety profile compared to retinol, SME may be the next-generation of natural alternatives to retinoids.
... Bakuchiol has been proposed as a potential alternative to retinol, showing a retinol-like mechanism of action without inducing adverse effects. 10,11 Active principles based on microorganisms' extracts (such as prebiotics and postbiotics) have also been described to exert benefits for different skin conditions, including skin aging. 12,13 The combination of such compounds, with low doses of retinol to avoid adverse effects, could be a promising option for a skin photoaging treatment as an alternative to the usage of retinoids at high doses. ...
... Surprisingly, the retinol + bakuchiol combination downregulated the expression of COL1A1, COL3A1, and COL5A1, while previous research indicates that both compounds should increase collagen levels. 10 These differences might be due to interindividual variability, the concentration of the compounds, the duration of the treatment, or the combined effect of both compounds used together. Interestingly, a common effect observed in retinol + bakuchiol + Lactococcus lysate and retinol 25 µM but not observed in retinol + bakuchiol and retinol 10 µM is the upregulation of autophagy-associated genes. ...
Article
Full-text available
Retinoids have proven to be effective in skin photoaging treatments. However, undesired side effects limit both their use and dosage in skin care routines. The aim of this research was to test the skin antiaging efficacy of a new combination of compounds including retinol at low doses, bakuchiol, and Lactococcus lysate. Skin aging markers were studied in vitro by qPCR, fibroblast growth stimulation assay, microscopy, and in a full thickness 3D reconstructed skin model by histological analysis. The combination of compounds significantly increased the expression of genes involved in extracellular matrix, growth factors, antioxidant defense, and autophagy, and showed an increased cell proliferation and migration in human dermal fibroblasts. The 3D skin model studies showed an increase in epidermal thickness and the levels of Ki67, procollagen I, COLIV, filaggrin, FGF2, TGFβ1, and cytokeratin 14, which reflects an increase in epidermal regeneration. These results indicate that this combination of compounds is a promising and effective treatment for skin aging and represents a good alternative to the use of high doses of retinoid
... Bakuchiol has recently emerged as a formidable defender against organ damage, offering protection against bone loss and delay in osteoporosis by exerting estrogen-like effects (Xin et al., 2019). As an analog of retinol, bakuchiol acts as an anti-aging compound through retinollike regulation of gene expression (Chaudhuri and Bojanowski, 2014). Furthermore, Bakuchiol demonstrated potent cytotoxic effects in human gastric cancer cells (SGC-7901), exhibiting doseand time-dependent effects (Lin et al., 2016). ...
Article
Full-text available
Introduction: The sustained synthesis of gold nanoparticles (GNPs) has gained significant attention in biomedical applications. In this study, we explored the antibacterial and anticancer potential of bakuchiol-mediated gold nanoparticles (Bak-GNPs). Bakuchiol, a natural compound found in Psoralea corylifolia seeds, serves as both a reducing and stabilizing agent for green synthesis of GNPs. Our objectives include network analysis, molecular docking, synthesis of GNPs, characterization, and antipathogenic and anticancer efficacy of Bak-GNPs against lung and liver cancers. Methods: Protein-protein interaction networks were analyzed to identify effective protein targets for bakuchiol in lung and liver cancers. A molecular docking study was performed to validate the efficacy of the target protein against lung and liver cancer. Furthermore, Bak-GNPs were synthesized using bakuchiol and characterized by various techniques such as UV-visible spectroscopy, dynamic light scattering (DLS), zeta potential transmission electron microscopy (TEM), and Fourier-transform infrared (FTIR) spectroscopy, and their potential against pathogens and lung and liver cancers. Results: GNAI3 emerged as the most promising target, with a binding energy of −7.5 kcal/mol compared to PTGER3’s −6.9 kcal/mol, different characterization techniques revealed the successful synthesis of Bak-GNPs. Bak-GNPs exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria, as confirmed by minimum inhibitory concentration (MIC) values. Bak-GNPs demonstrated significant anticancer effects on A549 (lung cancer) and HepG2 (liver cancer) cells, with IC50 values of 11.19 μg/mL and 6.6 μg/mL, respectively. Induction of apoptosis and inhibition of cell proliferation were observed in both the cell lines. The increased production of reactive oxygen species (ROS) contributes to its anticancer effects. Discussion: This study highlights promising biomedical applications of bakuchiol-mediated GNPs. This green synthesis approach using bakuchiol provides a sustainable method for producing nanoparticles with enhanced biological activities. Further exploration of the pharmacological properties and mechanisms of Bak-GNPs is required to optimize their therapeutic efficacy for clinical use.
... This compound functions as an antiaging agent through gene expression regulation similar to retinol. 37 Our results show that PAPE is comparable in effectiveness to topical retinoids and bakuchiol: wrinkles were reduced by 34% after using face cream with 3% PAPE for only 4 weeks and 25% when using 1.5% PAPE. ...
Article
Full-text available
Background The increasing quest for effective and safe antiaging skincare solutions has led to a surge in the exploration of natural compounds such as phenolic acids. Despite the proven efficacy of traditional antiaging ingredients like retinol, their associated side effects have necessitated the search for alternatives. Aims This study aimed to assess the anti‐wrinkle efficacy of a standardized phenolic acids polymer extract (PAPE) from propolis, employing both in vitro and clinical methodologies to explore its suitability as a novel antiaging skincare ingredient for sensitive and nonsensitive skin types. Patients/Methods The study comprised of evaluating PAPE effects on key skin health biomarkers in dermal fibroblasts and keratinocytes. A double‐blind, randomized clinical trial involving female participants aged 30–70 years assessed the wrinkle‐reducing effectiveness of face creams formulated with two concentrations of PAPE (1.5% and 3%) over a 28‐day period. Results In vitro studies indicated that PAPE could modulate inflammation and tissue remodeling biomarkers. The clinical trial demonstrated that applying PAPE‐enriched cream resulted in significant wrinkle reduction, with 25% and 34% improvements for the 1.5% and 3% PAPE formulations, respectively. Subjective feedback from participants further validated the antiaging efficacy and overall satisfaction with the product. Conclusion Incorporating PAPE offers a compelling antiaging solution, significantly reducing wrinkle depth with a favorable safety profile. The study substantiates PAPE's potential as an effective and safe alternative to conventional antiaging ingredients, aligning with the cosmetic industry's shift toward natural, evidence‐based formulations.
... Bakuchiol, a meroterpene phenol, regulates gene expression of retinoic acid receptors, collagen, and extracellular matrix via a similar antiaging mechanism as retinol [27,28]. ...
Article
Full-text available
Cosmeceuticals, the bridge between pharmaceuticals and cosmetics, contain biologically active ingredients that may improve the skin's overall appearance. As the market, accessibility, and popularity of cosmeceuticals increase, it is essential to understand the safety and efficacy of such products. This systematic review aims to examine published clinical studies involving the use of cosmeceuticals for antiaging to provide evidence-based recommendations based on available efficacy and safety data. PubMed, Embase, and Cochrane were systematically searched on January 1, 2023 using PRISMA guidelines. Strength of evidence was graded using the Oxford Centre for Evidence-Based Medicine guidelines. Clinical recommendations were made based on the quality of the existing literature. A total of 153 articles regarding the use of cosmeceuticals for treatment of antiaging were identified. After screening of titles, abstracts, and full text, 32 studies involving 1236 patients met inclusion criteria, including 20 randomized controlled trials (RCTs) and 12 non-randomized open-label clinical trials for Vitamin C, Retinol, Bakuchiol, Tetrahydrojasmonic acid, Growth Factors, Methyl Estradiolpropanoate, Timosaponin A-III (TA-III), Protocatechuic acid, Grammatophyllum speciosum, and Jasmine rice panicle extract. Retinol and vitamin C for antiaging received a Grade A for recommendation. Methyl estradiolpropanoate, bakuchiol, tetrahydrojasmonic acid, and growth factors received a recommendation grade of C. The remaining ingredients were assigned an inconclusive grade of recommendation due to lack of evidence. Cosmeceuticals included in the review had favorable safety profiles with few significant adverse events. The review analyzes numerous different ingredients to provide an evidence-based approach to decision-making for consumers and physicians on the use of cosmeceuticals for antiaging. Limitations to our review include a limited number of randomized controlled trials and a need for long-term data on each cosmeceutical's efficacy and safety. Future research is needed to establish the long-term effectiveness and safety of cosmeceuticals.
Conference Paper
Full-text available
The treatment of wrinkles with tretinoin has proven to be effective, but higher concentrations are associated with increased side effects such as dry skin, redness, and peeling. The objective of this study was to compare the efficacy of facial wrinkle treatment using 1% Bakuchiol combined with 0.025% Tretinoin versus 0.025% Tretinoin alone. The study involved 24 male and female volunteers aged between 25-45 years. One side of the face was randomly treated with 1% Bakuchiol combined with 0.025% Tretinoin, while the other side was treated with 0.025% Tretinoin alone for 12 weeks. Wrinkle assessment was performed using the Rao Goldman 5-point visual scoring scale, wrinkle depth, and skin elasticity measurements at weeks 4, 8, and 12. A repeated measures ANOVA test was used to compare the two groups, and participant satisfaction and side effects were evaluated using McNemar’s test. A p-value of <0.05 was considered statistically significant. The study found that wrinkle reduction achieved by using 1% Bakuchiol combined with 0.025% Tretinoin was comparable to using 0.025% Tretinoin alone. Keywords : Wrinkles, Bakuchiol, Tretinoin
Article
Full-text available
Background Aging is a physiological phenomenon in the process of life, and skin aging has a significant impact on human appearance. Therefore, the search for methods to delay skin aging is of great significance for improving the quality of human life. Materials and Methods This study investigated the anti‐photoaging effect of Tricholoma matsutake (T) extract composition combined with bakuchiol (B) and ergothioneine (E), and explored its potential mechanism through transcriptome, metabolomics, and network pharmacology. Results 57 main chemical components are identified from the ethanol extract of T. matsutake (T), including D‐carnitine (24.55%), α,α‐trehalose (15.56%), DL malic acid (8.99%), D‐(−)‐quinic acid (7.46%), erucamide (7.04%) and so on. After TBE treatment, inflammation of the mice dorsal skin is significantly minimized. Hematoxylin and eosin (H&E) staining and toluidine blue staining reveal that TBE has an anti‐inflammatory effect on the back skin tissue of mice. Masson staining shows that TBE has a repair effect on mice dorsal skin tissue. In addition, the inflammatory factors (IL‐1β, IL‐6, TNF‐α) in the mice dorsal skin tissues are significantly reduced but collagen (COL‐1) is significantly increased. By cellular immunofluorescence assay, TBE is shown to promote PPAR‐α expression in cells. Transcriptomics, metabolomics, and network pharmacology have revealed that TBE can regulate exogenous stimuli and cancer‐related signaling pathways to prevent skin aging. Conclusion The results suggest that TBE can be a beneficial supplement to natural anti‐aging.
Article
Bakuchiol (BAK) is a natural phenolic meroterpene isolated from the fruits of Psoralea corylifolia that exhibits a variety of pharmacological effects, including anti-aging, anti-microbial, hyperpigmentation, and anti-cancer activities. Furthermore, the usage of BAK is gaining popularity amongst researchers since it does not induce the same negative reactions as topical retinoids, such as blistering and scaling, allowing greater adoption for individuals with sensitive skin. The growing trend towards “clean” skin care products, as well as the hunt for retinoid substitutes, has elevated BAK to the status of a “must have” component in cosmetology and dermatology. Although, the pathogenesis of BAK is not completely understood yet it is known to play a pivotal role in acting as a scavenger of free radicals thus exerting an antioxidant effect which is helpful in the management of various skin disorders. It also regulates the expression of collagen and extracellular matrix synthesis enzymes which aids in reversing the signs of photo-aging. Moreover, natural sources of BAK are also being employed in traditional Chinese and Indian medicines due to their antitumor and anti-inflammatory properties. In this review, we have provided the occurrence, extraction, isolation methods, and structure-activity relationships of BAK. Moreover, this review discusses the pharmacological benefits of BAK, its novel and marketed formulations, and a brief overview of its patents
Chapter
This book delves into the world of natural sources from medicinal plants, microbes, and fungi, to lichen, algae, and clay minerals that have been used for centuries in traditional medicine. These sources are rich in bioactive secondary metabolites that have a wide range of applications in various industries, including cosmetics and personal care products. This book provides a comprehensive guide to secondary metabolites for cosmeceutical purposes, regulatory perspectives for cosmeceuticals in different countries, and allergic responses from these secondary metabolites. Additionally, this book discusses the impact of nanotechnology on cosmetic products such as skin and hair care. Bioprospecting of Natural Sources for Cosmeceuticals is a valuable resource for researchers and graduate students in chemistry, botany, biotechnology, microbiology, cosmetic science, and the pharmaceutical sciences. It is also useful for those researching traditional medicine systems and those in the microbiology, biotechnology, pharmaceutical, and nanoscience industries.
Article
Full-text available
KEY WORDS: acne, bakuchiol, antioxidant, anti-inflammatory, antibacterial, matrix metalloprotease ABSTRACT: Bakuchiol, a meroterpene of plant origin, is shown here to act against four major pathophysiologic features that cause acne, suggesting its use to complement and/or enhance the effectiveness of current anti-acne agents. In addition, the material is non-irritating, presents no photo-or hydrolytic-stability issues and is easy to use.
Article
Full-text available
OBJECTIVE: To study the nephrotoxicity induced by bakuchiol alone and bakuchiol combined with psoralen and to explore its mechanism. METHODS: The cytotoxicities of bakuchiol and bakuchiol combined with psoralen were investigated using human renal tubular epithelial cell lines (HK-2) , in presence or absence of hepatic S9 mixture. The HK-2 cells were exposed culture medium alone (blank control), 0.5% DMSO (vehicle control), aristolochic acid I (AA I; positive control) , psoralen 5 μ-L-1 group, bakuchiol 5, 10, 20, 30 and 40 μ-L-1 groups, and bakuchiol + psoralen (20+5) , (30+5) and (40+5) μmol·L-1 groups, respectively. The cell viabilities were examined by MTT assay; cell membrane injuries were examined by detecting lactate dehydrogenase ( LDH ) release rate ; and the morphological changes in HK-2 cells were observed with contrast microscope. The rate of cell apoptosis was detected by Annexin V/PI staining, and cell cycle was detected by PI staining with flow cytometry. RESULTS: No cytotoxicity was found in psoralen 5 μmol·L-1 group. The HK-2 cell viabilities were significantly reduced after 4, 24, 48 and 72 h of exposure to either bakuchiol 20, 30 and 40 μmol·L-1 groups or bakuchiol + psoralen (20+5), (30+5) and (40+5) μmol·L-1 groups in a time- and concentration-dependent manner. The IC50 values of bakuchiol were (26.4±4.8), (21.8±0.6) and (24.1±0.8)μmol·L -1 for 24, 48 and 72 h exposure, respectively. The cytotoxicity of bakuchiol was significantly decreased in presence of hepatic S9 mixture. The LDH release rate of HK-2 cell increased significantly after 24 h of exposure to bakuchiol 20, 30 and 40 μmol·L-1 or bakuchiol + psoralen groups. With the concentration and time increasing, the HK-2 cells became more and more contracted and rounded. In bakuchiol 40 μmol·L-1 or bakuchiol + psoralen (20+5), (30+5) and (40+5) μmol·L-1 groups, HK-2 cells showed apoptotic characters. In bakuchiol or bakuchiol + psoralen groups, apoptotic cells significantly increased and cells in G 2 phase markedly decreased. CONCLUSION: Bakuchiol has a significant cytotoxicity in HK-2 cells, and combined with psoralen can not decrease its toxicity. The cytotoxicity of bakuchiol is significantly reduced in the presence of hepatic S9 mixture. The possible mechanisms of the renal cytorotoxicity of bakuchiol are as follows: Circle digit 1 direct damage to the cell membrane; Circle digit 2 inducing cell apoptosis; Circle digit 3 inhibiting intracellular DNA synthesis and block cell mitosis and proliferation.
Article
Full-text available
Retinol is an ingredient used in cosmetic products for reducing the appearance of the signs of aging and photo-damage. Currently, most of these products contain 0.1% of retinol. However, at this concentration, some irritation can occur. We have evaluated in vitro and in a clinical study the potential efficacy of a combination of actives to improve the facial skin aging signs while using low concentration of retinol. We demonstrated, in vitro, that a chromone derivative, 5,7-di-hydroxy-2-methyl chromone (DMC), is able to enhance the collagen synthesis in culture of normal human dermal fibroblasts. The enhancement of retinol anti-wrinkle efficacy by DMC was confirmed in a small scale clinical trial. Specifically, a product associating low concentration of retinol (0.04%) and DMC (0.1%) in combination with low mo-lecular weight hyaluronic acid fragments (50,000 Dalton of average molecular weight) has been applied topically for 8 weeks. Clinical results show significant improvement of various signs of facial skin aging such as wrinkles, pigmentary spots, tone unevenness, dullness and the overall photo-damage score. Improvements were still visible 4 weeks after the cessation of the test product application. This study demonstrates that significant lasting improvement of facial skin aging can be obtained with well tolerated low concentration of retinol when adequately formulated with other anti-aging ingredients.
Article
https://deepblue.lib.umich.edu/bitstream/2027.42/154473/1/fsb2010009001.pdf
Chapter
Vitamin A is involved in the biosynthesis of the visual pigment rhodopsin (1), in embryogenesis (2), as well as in cell growth and differentiation (3). It exists in interconvertible forms as retinol, its esters (the main storage form in the body) and retinaldehyde, whereas the latter is irreversibly converted to retinoic acid, the biologically active form of vitamin A that binds to nuclear receptors and modulate gene expression (Fig. 1) (4,5). Retinoic acid exists as three cis/trans isomers: all-trans-, 9-cis- and 13-cis- retinoic acid; all-trans-retinoic acid (retinoic acid, tretinoin) binds to the nuclear receptors such as retinoic acid receptor (RAR)-α, β, and γ with a high affinity, 9-cis-retinoic acid (alitretinoin) binds to RAR-α, β, γ and retinoid X receptor (RXR)-α, β, γ with a high affinity, whereas 13-cis-retinoic (isotretinoin) does not bind to nuclear retinoid receptors with significant affinity (6,7).
Article
The sections in this article are: Manifestations of Skin Permeability Structure of the Skin Relevant Structural Features of the Whole Skin The Stratum Corneum Regional Variations in Structure Human Versus Other Mammalian Skin Biophysics of Skin Permeability Mathematical Analysis of Skin Permeability Steady‐State Permeability of Skin—Fick's Law Appendageal Diffusion Concentration Levels in the Skin Regional Variations in Permeability Effect of Solvents and Surfactants Water Aprotic Solvents Surfactants Organic Solvents
Article
Bakuchiol, a terpene phenol from Psoralea corylifolia Linn has only one asymmetric centre. By suitable correlation with (+)-linalool on the one hand and, with (+)-3-methyl-3-methoxy-carbonyl-n-valeria acid on the other, it has been shown to possess (S)-chirality.
Article
Isolation and structure elucidation of a novel monoterpene phenol, bakuchiol, from the seeds of Psoralea corylifolia Linn, is described.